Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516008-41-00

Acronym

VMX-SPN-212-001

Enrollment

Registered

2024-12-10

Start date

2025-01-29

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026